Rite Aid and Heritage Provider Network last month announced a new agreement to bring the Rite Aid Health Alliance program to HPN's chronic and polychronic patients in Southern California.
The new KL1Plus double counts the tablets it dispenses and can then store the count data for up to 10 years.
AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.
Commentary published online Monday addresses the controversy surrounding the high costs of new Hepatitis C virus treatments and implications for the growing specialty pharmacy market.
Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.
Sandoz on Monday announced an agreement with Anacor Pharmaceuticals to obtain exclusive rights to commercialize Kerydin (tavaborole) topical solution, 5%, through its branded dermatology business, PharmaDerm.
Teva Pharmaceutical Industries on Monday announced that its acquistion of Labrys has been completed. The acquisition brings to Teva LBR-101, which is currently in phase-2b clinical trials for prevention of chronic and episodic migraines.
The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
There is “something brewing in Congress” these days, NACDS president and CEO Steve Anderson wrote in a July 16 newsletter to NACDS chain members.
Diplomat announced it has acquired MedPro Rx, a specialty pharmacy focused on specialty infusion therapies including hemophilia and immune globulin.